Search

everythinglearnresearchcommunity

for

Search:↓

Men with severe hair loss may have poorer sperm quality.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Platelet-rich plasma shows promise for skin and hair treatments but needs more research and standardization.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

New treatments for male hypogonadism are effective and should be personalized.

Finasteride reduces hair growth better, but spironolactone has more side effects.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Engineered exosomes show promise for improving wound healing but face challenges in clinical use.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

A woman's health issues were caused by arsenic poisoning from kelp supplements.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

The triterpenoids from Ganoderma lucidum can block testosterone effects and may help treat enlarged prostate.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.